Related Experiment Video
Updated: May 22, 2026
09:05
A Novel Clinical Grade Isolation Method for Human Kidney Perivascular Stromal Cells
Published on: August 7, 2017
Kidney injury and cell therapy: Preclinical study
Rosa Maria Cabral1, Maíra S Ferraz, Márcia dos S Rizzo
1Department of Veterinary Clinical and Surgery, Federal University of Piauí (UFPI), Teresina, Piauí, Brazil. rosacabral@ufpi.edu
Microscopy Research and Technique
|May 24, 2012
Summary
Agoutis effectively model gentamicin-induced kidney disease. Bone marrow mononuclear cell (BMMC) infusion showed significant migration to renal injury sites, suggesting therapeutic potential.
Area of Science:
- Nephrology
- Regenerative Medicine
- Animal Models
Background:
- Gentamicin sulfate can induce kidney damage, mimicking human nephrotoxicity.
- Bone marrow mononuclear cells (BMMC) are investigated for their regenerative potential in tissue repair.
- Agoutis serve as a preclinical model for studying kidney diseases and therapeutic interventions.
Purpose of the Study:
- To evaluate agoutis as a model for gentamicin-induced kidney disease.
- To analyze the histological and immunofluorescence changes in agoutis' renal parenchyma after BMMC infusion.
- To assess the migration of Hoechst®-stained BMMC to sites of renal injury.
Main Methods:
- Induction of kidney disease in agoutis using gentamicin sulfate over 4 months.
- Infusion of Hoechst®-stained BMMC into test and control groups.
- Histological and immunofluorescence analysis of renal parenchyma.
- Comparison between gentamicin-induced disease, cell therapy, and control groups.
Main Results:
- Histological analysis revealed interstitial lesions characteristic of human kidney disease, including tubular necrosis and fibrosis.
- Immunofluorescence analysis indicated significant migration of BMMC to renal injury sites in the cell therapy group.
- Agoutis demonstrated typical pathological features of gentamicin-induced nephropathy.
Conclusions:
- Agoutis are a suitable animal model for studying gentamicin-induced kidney disease.
- BMMC infusion shows promise, with cells migrating to damaged kidney areas.
- Further research can explore BMMC therapy for kidney injury.
Related Concept Videos
01:29Acute Kidney Injury II: Pathophysiology
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:22Acute Kidney Injury I: Introduction
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...